Skip to main content
. 2019 Jan 18;36(4):777–786. doi: 10.1007/s10815-019-01406-z

Table 1.

Clinical, biochemical, and seminal characteristics of controls and obese patients

Controls (n = 10) Obese patients (n = 20) P
Age (years) 34 ± 5 40 ± 8 0.055
Weight (kg) 77 ± 8 146 ± 27 0.000
Body mass index (kg/m2) 24 ± 2 48 ± 9 0.000
Excess body weight (kg) 3 ± 6 70 ± 26 0.000
Total cholesterol (nmol/L) 177 ± 33 192 ± 33 0.381
Low-density lipoprotein cholesterol (nmol/L) 2.90 ± 0.78 3.57 ± 0.78 0.038
High-density lipoprotein cholesterol (nmol/L) 1.11 ± 0.18 0.96 ± 0.18 0.063
Triglycerides (nmol/L) 1.23 ± 0.50 1.98 ± 0.79 0.025
Total testosterone (nmol/L) 21.6 ± 6.0 12.9 ± 5.8 0.001
Sex hormone–binding globulin (nmol/L) 4.1 ± 1.3 2.9 ± 0.8 0.011
Free testosterone (pmol/L) 439 ± 103 302 ± 137 0.008
Estradiol (pmol/L) 84 ± 15 147 ± 48 0.008
Follicle-stimulating hormone (U/L) 2.6 ± 1 3.6 ± 1.9 0.199
Luteinizing hormone (U/l) 4.1 ± 0.6 3.5 ± 1.3 0.123
Fasting glucose (mmol/L) 5.1 ± 0.7 6.8 ± 3.6 0.328
Fasting insulin (pmol/L) 49 ± 28 181 ± 83 0.000
Semen volume (mL) 3.7 ± 1.9 2.8 ± 1.3 0.281
Sperm concentration (106/mL) 72.5 ± 18.3 40.9 ± 34.9 0.038
Total motility (%) 58 ± 4 37 ± 18 0.001
Progressive motility (%) 43 ± 3 18 ± 7 0.001
Immobile (%) 43 ± 4 64 ± 18 0.001

*Data are shown as means ± SD